Learn More
Cayman Chemical ANTIBODY TAS 102 25mg

Supplier: Cayman Chemical 2393225 MG
An orally bioavailable combination of the antimetabolite nucleoside analog TFT with the TPase inhibitor TPI; inhibits tumor growth by 65.7 and 44.9% in HCT116 and KM12C colon cancer xenograft mouse models, respectively (150 mg/kg per day for 14 days)
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.